Article
Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Current opinion in hematology - 1 Jan 2022
Cobo Isidoro, Tanaka Tiffany, Glass Christopher K, Yeang Calvin
Abstract excerpt
PURPOSE OF REVIEW: Clonal hematopoiesis of indeterminate potential (CHIP), defined by the presence of somatic mutations in hematopoietic cells, is associated with advanced age and increased mortality due to cardiovascular disease. Gene mutations in DNMT3A and TET2 are the most frequently identified variants among patients with CHIP and provide selective advantage that spurs clonal expansion and myeloid skewing....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
